{"certainAgreement":{"otherDetails":"PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"This study terminated early with 21 subjects accrued out of 298 planned, therefore no statistical testing was performed. The termination was decided due to positive preliminary results from other palifermin studies."},"pointOfContact":{"email":"seiferheldw@nrgoncology.org","organization":"NRG Oncology","title":"Wendy Seiferheld"}}